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Abstract  
 2 
We describe a sensitive, robust, high-throughput method for quantifying the 
formation of micronuclei, markers of genome instability, in mouse 
erythrocytes. Micronuclei are whole chromosomes or chromosome segments 35 
that have been separated from the nucleus. Other methods of detection rely 
on labour-intensive, microscopy-based techniques. Here, we describe a 2 
day, 96-well plate based flow-cytometric method of micronucleus scoring that 
is simple enough for a research technician experienced in flow cytometry to 
perform. The assay detects low levels of genome instability that cannot be 40 
readily identified by classic phenotyping, using 25 µl of blood. Using this 
assay, we have screened >10,000 blood samples and discovered novel 
genes that contribute to vertebrate genome maintenance, as well as novel 
disease models and mechanisms. We discuss experimental design 
considerations, including statistical power calculation, provide troubleshooting 45 
tips, and discuss factors that contribute to a false-positive increase in 
numbers of micronucleated red blood cells and experimental variability. 
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Editorial summary: This protocol describes a sensitive, robust, high-
throughput method for quantifying the formation of micronuclei in mouse 50 
erythrocytes. It detects low levels of genome instability and can be used to 
identify novel genome maintenance genes and models. 
 
INTRODUCTION 
Micronuclei are extra-nuclear segments of chromatin that can arise as a result 55 
of DNA double-strand breaks or mitotic-spindle-apparatus dysfunction. 
Micronuclei form infrequently during mitosis of healthy cells, and may either 
be acentric chromosomal fragments or whole chromosomes that have failed 
to be incorporated into the nucleus at the completion of mitosis1 (Fig. 1a and 
1b). The use of micronuclei as a means to quantify cytogenetic damage was 60 
originally proposed by Evans et al.2. Cells derived from patients with 
hereditary genome-instability disorders, such as Ataxia telangiectasia and 
Fanconi anemia, have a high frequency of micronucleus formation, and 
micronucleus assays can be used to aid the diagnosis of these disorders 3,4. 
In addition, many genome instability disorders predispose to cancer, and 65 
genome instability is a hallmark of spontaneously arising cancers5. 
Recent genomic analyses have identified a novel form of genome instability in 
cancer cells, a phenomenon termed ‘chromothripsis’6. Chromothripsis 
involves up to thousands of clustered chromosomal rearrangements, thought 
to occur as a single event and confined to genomic regions in one or a few 70 
chromosomes. This phenomenon has sparked further interest in micronuclei, 
which have been shown to undergo highly error-prone DNA replication and 
DNA breakage7,8. It is thought that DNA fragments could be reassembled in 
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the wrong order by the process of non-homologous end-joining, leading to 
massive chromosomal rearrangements in mitosis. Micronuclei have been 75 
shown to re-incorporate into the same nuclear compartment as the main 
chromosomes during mitosis7. This raises the possibility that genomic 
reintegration of a genomically rearranged micronucleus might occur in 
cancers and could be selected for if they cause an oncogenic event such as 
loss or disruption of a tumour suppressor gene7,9,10. 80 
Elevated levels of micronuclei have been associated with tumor predisposition 
in genetically modified mice,11-13, and micronucleus assays have been used to 
assess the carcinogenic potential of compounds in toxicity studies, and for 
biomonitoring mice and humans that have been exposed to mutagens such 
as radiation14-17.  85 
 
Development and applications of the method 
Fliedner et al. first proposed the idea of scoring micronuclei as a biological 
dosimeter of radiation exposure in humans18. Measuring numbers of 
micronuclei in mammalian red blood cells is relatively straightforward because 90 
normoblasts (erythrocyte precursor cells that reside in the bone marrow) expel 
their nucleus during red blood cell development, leaving behind any 
micronuclei that have formed (Fig. 1a and 1b). In the blood, micronucleated 
erythrocytes were first identified by microscopy using a basophilic stain, and 
were called ‘Howell-Jolly bodies’ after the two scientists who first discovered 95 
them19-22. While micronucleated red blood cells are extremely rare in humans, 
in part due to their efficient clearance by the spleen, mice are less efficient at 
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clearing micronucleated red blood cells from the peripheral circulation, and so 
they are more readily detected in this model organism23.  
 100 
Hutter and Stohr24 were the first to describe a flow cytometry–based method 
of scoring micronucleated erythrocytes from bone-marrow, which they 
compared with standard microscopy-based scoring. Their method involved 
the fixation of samples followed by the addition of the fluorescent DNA stain 
4’,6-diamidino-2-phenylindole (DAPI) and the protein fluorochrome 105 
Sulforhodamine 101 to discriminate between normal anuclear erythrocytes 
and micronucleated erythrocytes. Their method was later refined and applied 
to the analysis of peripheral erythrocytes using a variety of DNA stains, 
including DAPI, Hoechst and propidium iodide (PI)25,26. 
In mice, 1-3%  of red blood cells are reticulocytes (RET), immature 110 
erythrocytes that are characterized by their cytoplasmic reticular mesh of RNA 
and their large size, whereas the remaining 93-94% are mature 
normochromatic erythrocytes (NCE), which are characterized by their ‘donut’ 
shape and the absence of a nucleus (Fig. 1a).  In 1992, Grawé and co-
workers described a method that distinguished between micronucleated RET, 115 
which are thiazole orange positive, and NCE using a dual-laser flow cytometer 
configuration25,27. The distinction between RET and NCE is important for 
assessing the effects of genotoxic challenge because micronucleated RET 
are indicative of recent damage, whereas micronucleated NCE are indicative 
of damage caused >72 hours earlier. RET can be distinguished from NCE by 120 
studying the expression of the mouse transferrin receptor (CD71), which is 
present on the surface of most dividing hematopoietic progenitor cells28. In 
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1996, Dertinger and co-workers refined the method using a fluorescein-
conjugated monoclonal antibody to the CD71 receptor, which labels the RET 
population29. Using PI to stain DNA (after removal of RNA from RET by 125 
incubation with ribonuclease) simplified the assay by enabling the use of a 
single-laser flow cytometer for enumeration of cells (Patent US6100038A and 
US5858667A)30.   
 
In 2003, Shima et al. used the assay developed by Dertinger and co-workers 130 
to genetically screen mice for novel genes required for vertebrate genome 
maintenance31,32. Here, we have scaled-down Dertinger’s method to perform 
the assay in 96-well plates (Fig. 2), which we have used to assess genome 
stability in >10,000 mice as part of a large-scale, reverse genetic screen, in 
association with the Mouse Genetics Project at the Wellcome Trust Sanger 135 
Institute, UK33. The program screens genetically modified mice as part of an 
international effort to associate gene function with developmental 
abnormalities and disease. By combining the assay with high-throughput 
phenotyping of mice, we have identified several novel mouse models of rare 
genome-instability disorders, novel genome maintenance genes, including 140 
Cenpj and Mysm1, and cancer predisposition genes including Slx411,34-38. If 
such a screen were to be performed for the human population, albeit with a 
slightly modified method that enriches for RET prior to assay processing due 
to the efficient clearance of micronucleated erythrocytes by the human 
spleen39, the assay could aid the diagnosis of novel genome instability 145 
syndromes or identify individuals that may be predisposed to cancer due to 
elevated basal levels of genome instability. Furthermore, by incorporating a 
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challenge with ionizing radiation into the mouse phenotyping pipeline, we 
have identified radiation-sensitive mutants, which exhibit increased levels of 
micronucleated-RET after irradiation but not before. Within this manuscript, 150 
we provide additional details on data analysis, troubleshooting and potential 
sources of false-positive increases in numbers of micronucleated red blood 
cells and data variability. 
 
Our high-throughput flow-cytometric micronucleus assay is relatively quick, 155 
inexpensive, and simple to perform. It uses equipment that is available in 
most research organizations, and is reliable if performed according to the 
instructions provided herein. It therefore makes an ideal test for the detection 
of genome instability in vivo that is minimally invasive and does not require 
the death of the animal, meaning that it can easily be incorporated into a 160 
phenotyping screen. We provide step by-step technical advice, as well as a 
troubleshooting guide with tips gleaned from our use of the method over the 
past few years.  
 
Limitations of the method 165 
The high-throughput micronucleus assay gives an indication of genome 
stability as measured by the frequency of micronucleated erythrocytes in a 
population. The assay does not provide information on the structure of the 
micronucleus and therefore does not distinguish between the different 
mechanisms of action of inducers, such as clastogens or aneugens. Neither 170 
does the assay inform on whether a cell has a single micronucleus or multiple 
micronuclei, as could be determined by conventional microscopy. Therefore 
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further experiments are needed to determine the structure of the micronucleus 
and mechanism of its formation. For example, we have previously shown that 
fibroblasts derived from Cenpj-deficient mice (1.5-fold increase in % 175 
micronucleated normochormatic erythrocytes) are prone to tetraploidy, as 
shown by multiplex metaphase fluorescent in situ hybridization and indicated 
by cell cycle analysis35. This suggested that micronuclei were likely the result 
of chromosome missegregation; fluorescence microscopy revealed that 
fibroblasts had an increased frequency of supernumerary centrosomes and 180 
multi-polar spindles which have been shown to cause aneuploidy35.  
Alternatively, micronuclei can also be detected in vitro using the cytokinesis-
block micronucleus cytome assay40. In addition to quantifying micronuclei, the 
cytokinesis-block micronucleus cytome assay also detects cytostasis, 
cytotoxicity and provides information on the structure of the micronucleus. 185 
This added information is useful for determining the likely mechanism of 
micronucleus formation. For example, nucleoplasmic bridges are a biomarker 
of misrepair and/or telomere end-fusions, whereas nuclear buds are a 
biomarker of elimination of amplified DNA and/or DNA repair complexes40. 
However, the cytokinesis-block micronucleus cytome assay is time-190 
consuming and relies on a complicated scoring system. In summary, the high-
throughput micronucleus assay is a fast and sensitive method for the 
detection of micronuclei, but further experiments are needed to ascertain the 
mechanism of its formation. 
 195 
Through screening for micronucleus induction in parallel with a large-scale, 
unbiased mouse phenotyping pipeline, we have identified several factors that 
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may influence the detection of true, micronucleated red blood cells with the 
assay. Regenerative anemia causes increased production of red blood cells 
(reticulocytosis) and activation of extramedullary hematopoiesis41. In extreme 200 
cases of reticulocytosis, such as that observed in 16-20 week old C57BL/6J 
Apcmin/+ mice (Suppl. Fig. 1a-b), the main nucleus may not be expelled during 
erythropoiesis, resulting in erythroblastosis, which is the presence of 
nucleated red blood cells in the peripheral circulation. The assay does not 
distinguish between micronucleated and nucleated red blood cells and so this 205 
causes a false-positive increase in % micronucleated-NCE (Suppl. Fig. 1a-b). 
With the high-throughput micronucleus assay, there is a positive correlation 
between % RET and % micronucleated-NCE (Suppl. Fig. 1b). The use of an 
anti-CD71 transferrin receptor antibody enables the researcher to quantify 
reticulocytes to ensure that numbers are within normal limits (e.g. for healthy 210 
C57BL/6 mice, RET should constitute 1-2% of the total red blood cell 
population; Suppl. Fig. 1c). Furthermore, the assay relies on the distinction of 
blood cells by size and granularity, and therefore any changes to these 
parameters could result in a false-positive increase in the number of 
micronucleated-red blood cells. As a rule of thumb, if other changes in other 215 
hematopoietic parameters are observed, such as but not limited to red blood 
cell distribution width (or ‘RDW’), we would confirm the micronucleated cell 
type using microscopy. A simple method to confirm a change in 
micronucleated-NCE would be to perform cell counts on fresh blood smears 
stained with May-Grumwald Giemsa (Fig. 1b) or on methanol-fixed blood 220 
samples co-stained with DAPI on slides (Fig. 1c and 1d). For the 
quantification of micronuclei from slides stained with May-Grunwald Giemsa, 
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we recommend counting >6000 red blood cells or cells from fifteen fields of 
view (40X magnification) per sample, for at least three mice per test group. 
For a wild-type mouse, we would expect to see 1-2 micronucleated cells/1000 225 
erythrocytes. For a positive-control mouse, we would expect to see at least 2-
4 micronucleated erythrocytes/1000 erythrocytes.  
 
Experimental design  
Test and control mice should be matched by sex, age and genetic 230 
background, since all of these factors influence micronucleus induction in 
mice (Box 1 and Fig. 3a-b). The assay is highly sensitive and reproducible if 
screening is performed with mice of the same sex that are bred on a pure 
genetic background (Fig. 3c). It is possible to detect minimal changes with 
statistical significance using the appropriate sample number (Box 1 and Fig. 235 
3d). The simplest way to generate positive control animals for the assay is to 
expose wild-type mice to genotoxic agents, including treatment with 1 mg/kg 
mitomycin C or 0.75 Gray irradiation (Box 2; Fig. 4a-b, respectively). 
Alternatively, several mouse models with elevated micronucleus levels, such 
as the Slx4-null mouse (Fig. 4c-e), have previously been characterized and 240 
mice, or their blood samples, could be requested from the corresponding 
author of the study (see review by Balmus & McIntyre42). Importantly, the 
experimenter should ensure that the experiment is performed in accordance 
with local animal research regulations and ARRIVE guidelines43.  
 245 
MATERIALS 
REAGENTS 
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 Laboratory mice (e.g. C57BL/6J mice from The Jackson Laboratory, 
(Maine, USA), #000664)  
 Methanol (CH3OH; e.g. Sigma-Aldrich, #494437) 250 
 Heparin (e.g. Sigma-Aldrich, #H3393; ≥180 U.S.P. (U.S. 
Pharmacopeia) units/mg) 
 Sodium chloride (NaCl; e.g. Sigma-Aldrich, #S3014) 
 Sodium phosphate dibasic (HNa2O4P; e.g. Sigma-Aldrich, #S5136) 
 Sodium bicarbonate (CHNaO3; e.g. Sigma-Aldrich, #S6297) 255 
 Hydrochloric acid (HCl; e.g. Sigma-Aldrich, #84415) 
 Ribonuclease A from bovine pancreas (RNase A; e.g. Sigma-Aldrich, 
#R4642; activity ≥ 70 Kunitz units/mg protein) 
 Fluorescein-isothiocyanate (FITC)-conjugated rat anti-mouse CD71 
transferrin receptor antibody (e.g. Southern Biotech, #1720-02; 0.5 260 
mg/ml) 
 Mitomycin C from Streptomyces caespitosus (MMC; e.g. Sigma-
Aldrich, #P4864) CRITICAL Only required if using MMC to produce 
positive control. 
 Propidium iodide 1.0 mg/ml solution (PI; e.g. Sigma-Aldrich, # P4864) 265 
 
EQUIPMENT 
 Flow cytometer capable of handling multi-titer-well plates (e.g. 96-well 
plate) and equipped with 488 nm blue and 561 nm green lasers (e.g. 
LSR FortessaTM with high-throughput sampler option, Becton 270 
Dickinson) or, alternatively, with only a 488 nm laser. 
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 Centrifuge with 4˚C setting (e.g. Eppendorf 5810R) or centrifuge 
located in a cold room 
 -80˚C freezer 
 pH meter (e.g. Meter Toledo MP220) 275 
 Biological safety cabinet (e.g. Fisher Scientific, #12372419) 
 Reciprocating shaker (e.g. Stuart SSL2) 
 Aluminum foil (e.g. Terinex) 
 Single-use 0.22 µm filters (e.g. Corning, #430521) 
 10 ml serological pipets (e.g. Corning - Product #4101) 280 
 15 ml polypropylene conical centrifuge tubes (e.g. Corning, #352097) 
 5 ml round bottom polystyrene tubes for flow cytometry (e.g. Corning, 
#352054) 
 96-deep-well plates with 0.8 ml capacity (e.g. ABgene, #AB-0859) 
 96-well clear flat bottom plate for flow cytometry assay (e.g. Corning, 285 
#353075) 
 1.5 ml microcentrifuge tubes (e.g. Eppendorf, #0030120191) 
 Flow cytometry data analysis software (e.g. FlowJo, Tree Star, Inc.) 
and statistical analysis software (e.g. Prism,  GraphPad) 
 Optional: live animal irradiator (e.g. CIS-IBL 437 C; C137) 290 
 Optional: sterile lithium-heparin-coated vacutainer blood-collection 
tubes (e.g. Microtainer, Beckton Dickinson, #365953) 
 
REAGENT SETUP 
Mitomycin C (MMC). Prepare MMC solution in a sterile laminar flow cabinet 295 
(Class II).  Prepare 0.5 mg/ml stock solution with sterile water. Store at 4˚C for 
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up to two weeks. CAUTION: MMC is potentially mutagenic or carcinogenic; 
wear gloves, safety glasses and a laboratory coat when handling.  
Heparin. Prepare a 500 U.S.P. units/ml (2.35 mg/ml Sigma-Aldrich H3393) 
solution in sterile PBS. Filter (0.22 µm filter) and aliquot 300 µl into 1.5 ml 300 
tubes and store at -20˚C for up to one year. Freeze-thaw no more than three 
times. The solution may be stored at 4˚C for several weeks in 1.5 ml tubes but 
evaporation occurs over longer periods.  
Fixative. >12 hours before blood collection, aliquot 2 ml methanol into 15 ml 
conical tubes in a chemical safety cabinet and cap tightly. It is recommended 305 
to prepare at least two tubes per blood sample from each mouse, but to 
process one sample and keep the second sample for technical repetition or 
for back-up. Place tubes in -80˚C freezer for >12 hours and less than one 
month. We do not recommend long-term storage of methanol aliquots in the 
freezer, rather, methanol should be stored in a suitable ‘flammables’ cupboard 310 
away from sources of ignition. CAUTION: methanol is flammable, corrosive 
and toxic, so aliquot in a chemical safety hood away from sources of ignition, 
and wear gloves, safety glasses and a laboratory coat when handling.  
Bicarbonate buffer. Prepare 0.9% NaCl, 5.3 mM sodium bicarbonate (84 
g/mole), and bring to pH 7.5 by adding HCl. Autoclave and store at 4°C for up 315 
to one year. A 10X stock solution can be prepared, autoclaved and stored at 
4˚C for up to a year, but pH must be determined for the 1X solution again 
when diluted for use. CAUTION: HCl is corrosive so wear gloves, safety 
glasses and a laboratory coat when handling, and pipette reagent in a 
chemical safety cabinet. CRITICAL: Bicarbonate buffer must be cold before 320 
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use, so allow plenty of time for cooling. If fixed blood samples are washed 
with warm buffer, they will turn brown and will be unsuitable for analysis.   
CD71/RNase solution. This solution should be freshly prepared. Working in 
dimmed lighting, prepare enough bicarbonate buffer/RNase/CD71-FITC 
antibody mix for the required number of samples plus an extra 10% (‘dead’ 325 
volume). To each sample, add 0.2 µl anti-CD71-FITC (0.5 mg/ml) and 7 µl 
RNase A (e.g. Sigma, #R4642, activity ≥ 70 Kunitz units/mg protein) to 
bicarbonate buffer (e.g. 72.8 µl) to make a total volume of 80 µl.  To test the 
activity of new batches of RNase, we recommend performing a dilution series 
and comparing profiles after incubation with, for example, 0, 4, 8, 12 µl 330 
RNase.  CRITICAL: Sufficient RNase A activity is required to digest the RNA 
present in reticulocytes; low-quality RNase A may lead to inaccurate results 
since PI binds to RNA as well as DNA (see Suppl. Fig. 2a-b for profiles 
associated with incomplete digestion of RNA). TROUBLESHOOTING  
Animals. We obtain our mice from The Jackson Laboratory (Maine, USA). 335 
The care and use of all mice used to generate data for this protocol was 
carried out in accordance with UK Home Office regulations, UK Animals 
(Scientific Procedures) Act of 2013. Our mice are maintained in a specific 
pathogen free unit on a 12 hours light: 12 hours dark cycle with lights off at 
7:30pm and no twilight period. The ambient temperature is 21±2˚C and the 340 
humidity is 55±10%. Mice are housed using a stocking density of 3–5 mice 
per cage (overall dimensions of caging: (LxWxH) 365x207x140 mm, floor area 
530 cm2) in individually ventilated caging (Tecniplast Seal Safe1284L) 
receiving 60 air changes per hour. In addition to Aspen bedding substrate, 
standard environmental enrichment of two nestlets, a cardboard Fun Tunnel 345 
 15 
and three wooden chew blocks are provided. Mice are given water and diet ad 
libitum.  
 
EQUIPMENT SETUP 
Flow cytometer. Warm up the lasers for half an hour and prepare the 350 
instrument for high-throughput sample analysis using a 96-well plate (refer to 
the manufacturer’s instrument setup guide). The fluorescence emitted from 
FITC-conjugated anti-CD71 and PI is collected through a 530/30 nm and a 
610/20 nm band-pass filter after excitation by the blue 488 nm and the green 
561 nm laser, respectively. Data resolution is improved and compensation is 355 
not required when the fluorochromes are excited and detected independently 
of each other using a 488 nm and 561 nm laser configuration. When a single 
488 nm blue laser is used in this experiment, compensation is required during 
data acquisition since FITC and PI have a slight spectral overlap (please refer 
to reagent supplier technical sheet), the same excitation wavelength and the 360 
same detection light path (please refer to your instrument technical 
specification). 
Set the high-throughput sampler to mix each sample two-to-four times before 
acquiring 200,000 events per sample at a rate of 1000-2000 events per 
second. The preparation of single-fluorochrome and unstained controls from 365 
surplus sample to setup the regional gates for the analysis of the erythrocyte 
cell population is included in the main protocol. CRITICAL STEP: maintain an 
acquisition rate of less than 2500 events per second on a volumetric flow rate 
of 0.5 µl-1 µl per second. A higher volumetric flow rate can result in an 
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increased rate of false positive events for the CD71-FITC-positive, PI-positive 370 
population. See Suppl. Fig. 2a and 2c.  TROUBLESHOOTING.  
******************* 
PROCEDURE 
 
Blood collection, fixation and storage TIMING: approximately 10 minutes 375 
per mouse. 
1 | Collect 50 µl of blood (for example, ~2-3 drops from a tail vein or retro-
orbital bleed) into 300 µl heparin solution in a 1.5 ml tube44. Alternatively, 
blood can be collected into a heparinized vacutainer; however, it must then 
be transferred to the heparin solution to ensure proper single-cell 380 
dissociation of the cells prior to fixation. CAUTION: blood must be 
obtained from mice using a technique that is approved by local regulatory 
bodies and/or ethics committees44. 
CRITICAL: Ensure the blood sample is fixed within 12 hours of collection 
to minimize the risk of sample degradation, which is one of the most 385 
common sources of false positives (Suppl. Fig. 3). TROUBLESHOOTING. 
2 | Rapidly expel 150 µl of heparin-blood mix directly over the 2 ml aliquot of 
cold methanol (taken straight out of -80°C freezer) using a pipette and cap 
the 15 ml tube. Repeat for duplicate tube. CRITICAL STEP: Do not put the 
pipette tip in the methanol and do not let the blood touch the side of the 390 
tube, or aggregation may occur. CRITICAL STEP: The temperature of the 
methanol must be -80˚C before fixation as warmer methanol causes the 
blood to turn red-brown (Suppl Fig. 2d) and alters the size and granularity 
of the blood cells, leading to a false positive increase in micronucleated-
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erythrocytes (Suppl. Fig. 3). The blood sample should remain bright red in 395 
fixative. TROUBLESHOOTING. 
3 | Invert the sample 4-5 times to prevent aggregation, and store the tubes at 
-80°C for at least 12 hours before continuing. We recommend that the 
tubes are returned to their original polystyrene packaging, as this provides 
added protection should the freezer fail. We do not recommend 400 
transferring samples to a -20°C freezer after fixation, as warmer methanol 
temperatures change the size and granularity of blood cells, which can 
result in a slight elevation of the micronucleated-NCE population (Suppl. 
Fig. 3). PAUSE POINT: When methanol fixed samples are stored at -80˚C, 
they remain stable for up to a year (Suppl. Fig. 2e and Suppl. Fig. 4a). At 405 
this stage, the 15 ml tubes of methanol fixed samples can be placed in a 
sealed bag, shipped on dry-ice and stored in a -80˚C freezer upon arrival 
at new destination.  
 
Sample preparation TIMING 3-4 hours for 96 samples 410 
4 | Working on ice, add 12 ml of cold (4˚C) bicarbonate buffer, cap and invert 
15 ml tubes to mix. Centrifuge at 500 g for 5 minutes at 4 ˚C. CRITICAL 
STEP: samples must remain cold, especially while the cells are in 
undiluted methanol; if samples become warm at this stage they may turn 
red-brown (Suppl. Fig. 2f) the size and granularity of blood cells can 415 
change and the data may be uninterpretable (Suppl. Fig. 3). TROUBLE 
SHOOTING.  
5 | Pour off the supernatant, add 200 µl cold bicarbonate buffer and 
resuspend the cell pellet by pipetting gently up and down. 
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6 | Transfer 20 µl of sample to each well in a 96 deep-well plate (800 µl/well 420 
capacity). Add 20 µl of any sample to three 1.5 ml microcentrifuge tubes 
for preparation of unstained control, PI-only control and CD71-FITC-only 
control, which are required for flow cytometry setup. 
7 | Add 80 µl of CD71-FITC/RNase solution to test samples in the plate and to 
the CD71-FITC-single-stain control tube. Add 7 µl RNase and 73 µl buffer 425 
to the unstained control and PI-only control tubes.  
TROUBLESHOOTING 
8 | Cover plate with foil and incubate for 45-60 minutes at 4˚C with gentle 
agitation (approximately 60 rpm) on a shaker. 
9 | Wash samples (in wells and eppendorf tubes) by addition of 600 µl cold 430 
bicarbonate buffer (4˚C) and centrifuge at 500 g for 5 minutes at 4˚C.  
10 | Pour off supernatant by quickly inverting the plate over a waste 
container. The cells will remain in the wells. Pipette off supernatant from 
control tubes.  Resuspend pellets in 500 µl bicarbonate buffer by pipetting 
gently up and down. 435 
11 | Transfer 200 µl sample to a clear, flat-bottomed 96-well plate.  The 
remaining sample can be stored at 4˚C and used for technical replication if 
required. 
 
Flow cytometric analysis TIMING: 2-3 hours for 96 samples 440 
 
12 | Transfer 500 µl of each control sample into 5 ml round-bottom 
polystyrene tubes.  
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13 | Using the unstained control, acquire events with logarithmic side-
scatter (SSC-A-log) versus linear forward scatter (FSC-A-Lin) axes. The 445 
SSC versus FSC plot should reveal two to three overlapping populations 
of red blood cells with reasonably well-defined edges.  Centre the main 
population (erythrocytes) using the voltage and gain settings, and create 
the first gate (R1) just inside the erythrocyte population (Fig. 5a).   
14 | Isolate doublets by plotting FSC-W-Lin versus FSC-A-Lin and set gate 450 
R2 around single cells (Fig. 5b). 
15 | Add 2.5 µl PI to the PI-only control tube, leave a few minutes and 
acquire events. Adjust the voltage and gain to ensure all events are within 
the axes and draw a quadrant gate to separate the positive and negative 
populations. Repeat for the CD71-FITC-only control.  455 
16 | Use the PI single-stain control to identify events caused by auto-
fluorescence (Suppl. Fig. 5c-d) and remove by setting gate R3 on the PI 
biexponential scale versus SSC biexponential scale axes (Fig. 5c and 
Ssuppl. Fig. 5d);  
17 | On CD71-FITC-biexponetial versus PI-biexponential axes, gate the 460 
four different populations (RET – Q1; MN-RET- Q2; MN-NCE-Q3; NCE – 
Q4; Fig. 5d). 
18 | Save the experiment settings on the flow cytometer. 
19 | Switch the flow cytometer from tube mode to multi-titer-well plate 
mode. 465 
20 | Set the volume to 70 µl, mixes to 4, volumetric flow rate to 0.5 µl or 1 µl 
per second (to achieve around 1000-2000 events/sec).  
 20 
21 | Add 1 µl PI to each well of the plate using a multipipettor, loading 24 
wells at a time. Loading more than 24 wells at a time may increase 
variability (see Suppl. Fig. 4b). Although pipetting 1 µl is not as accurate as 470 
pipetting larger volumes, our data suggest high assay reproducibility (see 
Box 1 for examples). We routinely use an 8-channel Biopette™ (1-10 µl) or 
an Eppendorf Multipette® plus. Mix by pipetting up-and-down with a multi-
channel pipette (20-200 ul), incubate for a few minutes. 
TROUBLESHOOTING 475 
22 | Load the saved protocol, acquire and save data. 
TROUBLESHOOTING 
23 | Export data, repeat the analysis (create gate R1 around erythrocytes, 
isolate doublets and set gate R2, remove auto-fluorescence by setting 
gate R3, gate the four populations) using appropriate software (e.g. 480 
FlowJo, TreeStar Inc.). 
24 | To calculate the % micronucleus (MN) formation use the absolute 
event counts for each of the indicated quadrants: 
% MN-RET = [MN-RET/(RET + MN-RET)] × 100 
 % MN-NCE = [MN-NCE/(NCE +MN-NCE)] × 100 
 
 485 
TIMING for 96 samples 
Day 1 (reagent setup): Prepare bicarbonate buffer (10 minutes), autoclave 
and place at 4˚C. Label 192 15 ml tubes (96 x 2), aliquot 2 ml methanol into 
each and place at -80˚C (approximately 2 hours). 
 21 
Day 2 (steps 1-3): Collect 96 blood samples into heparin solution. If 490 
experienced in the tail vein bleed technique, this should take approximately 4 
hours.   Fix blood in methanol (-80˚C; approximately 1.5 hours). 
Day 3 (steps 4-24): Wash samples in buffer, centrifuge and resuspend in 
buffer (approximately 2.5 hours), incubate for 45-60 minutes in CD71-
FITC/RNase solution, wash in buffer and centrifuge (15 minutes), add PI and 495 
analyze by flow cytometry (approximately 2 hours).   
 
 
TROUBLESHOOTING 
See Table 1 for troubleshooting guidance. 500 
 
ANTICIPATED RESULTS 
The anticipated results with the flow cytometric micronucleus assay depend 
on the mouse genetic background, sex, age and level of exposure to 
genotoxic agents (Box 1; Fig. 3 and Fig. 4). Any significant increase over the 505 
wild type mouse baseline can be identified with high sensitivity using simple 
statistics that are appropriate for the experimental design (Box 1). The 
successful procedure is dependent on proficient sample collection, storage, 
preparation and acquisition on the flow-cytometer (see Troubleshooting). 
Upon sample collection the blood should not be allowed to coagulate and the 510 
fixation should be done in timely manner in -80°C methanol. Upon fixation the 
solution should have a distinctive bright red color that will preserve throughout 
storage; brown coloration will indicate defective fixation. During data 
acquisition on the flow cytometer the quality of the blood preparation can be 
easily observed on the graph generated on side scatter logarithmic scale 515 
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(SSC-Log) versus forward scatter linear scale (FSC-Lin) where the total blood 
has a distinctive pattern that is easily distinguishable (Fig. 5a); deviations from 
this pattern might indicate sample degradation or defective fixation (see 
Troubleshooting). The comparison between the unstained, CD71-only, PI-only 
and the CD71/PI stained samples will demonstrate successful sample 520 
staining. The addition of wild-type and positive controls to each plate (see 
Experimental design considerations) will confirm that the assay has been run 
successfully.  
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Box 1 – Sources of variation in micronucleus frequency 
Below we highlight significant sources of variation in micronucleus frequency 550 
that should be taken into consideration during experimental design.  
 
Sex 
For all mouse strains that we have tested, the frequency of micronucleated-
NCE for males was significantly increased when compared to females. For 555 
example, female C57BL/6N mice have a mean of 0.14% micronucleated-
NCE, whereas the mean for males is 0.21% (P=0.0002, mixed model analysis 
where sex is a fixed effect and assay date a random effect; Fig. 3a). 
 
Genetic background 560 
The assay is sensitive enough to detect significant differences between inbred 
strains of mice (Fig. 3b). Compared with 129SvEv mice (n = 27), C57BL/6JIco 
mice (n = 15) have a higher basal level of %micronucleated-NCE (0.186% 
compared with 0.143%; P=0.0065; mixed model analysis for which core strain 
is a fixed effect and assay date a random effect). Relative to the variance of 565 
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129SvEv (i.e. variance of 1), the variance of C57BL/6JIco is similar (relative 
variance=1.18), whereas the variance of mixed strains is more than three 
times greater  (relative variance of B6Brd;129S5-Tyrc-Brd  = 3.29, 
CBACa;129S5 = 3.63 ; Fig. 3b), suggesting that data variability is greater for 
mice with mixed genetic background than for those with pure genetic 570 
backgrounds. This finding should be considered when determining statistical 
power. It should be noted that, when comparing mixed genetic backgrounds 
comprised of sub-strains of laboratory mice, the variance is low (Fig. 3b). For 
example, if we compare the variance of a mixed strain of mice, where all 
strains are historically derived from BL/6 mice, then the variance is similar to 575 
that of a pure inbred strain (variance of B6Brd;B6Dnk;B6N-Tyrc-Brd =0.92 
relative to the pure, inbred strain 129SvEv). In summary, assay sensitivity is 
highest when mice are of the same sex and are bred on a pure genetic 
background (Fig. 3c). 
 580 
Age 
DNA damage is thought to accumulate with age and, therefore, older mice 
may have higher frequencies of spontaneous micronucleus formation than 
young mice45. We recommend that mice are age-matched where possible.  
 585 
Assay date 
By performing the micronucleus assay as part of a large-scale phenotyping 
pipeline we have found that, as with other phenotyping variables, assay date 
is a significant source of variation.46. The variation with date arises from 
multiple factors including researcher, reagent lot, cage, mother and litter size. 590 
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This temporal variation has a significant impact on data analysis as readings 
taken on the same day are more similar than readings on different days. The 
simplest approach to manage this source of variation is to process all samples 
at the same time, which will enable the use of standard statistical methods 
such as the Student’s t-test. Where it is not possible to collect samples and 595 
process them on the same day, such as with a large-scale phenotyping 
pipeline, micronucleus data can be analyzed with a mixed model approach, 
where genotype is treated as a fixed effect and assay date as a random 
effect. This separates the genotype effect from the temporal variation by 
assuming that temporal variation is normally distributed with mean of zero and 600 
with a defined variance. We refer the reader to Karp et al. 2012 for further 
statistical design considerations with regard to assay date46.  
 
Statistical power  
Data from 200 blood samples obtained from male C57BL/6N wild-type mice, 605 
which were screened over seven assay dates, were used to determine the 
appropriate statistical method and associated statistical power. Across the 
seven datasets, the % micronucleated-NCE data was normally distributed, as 
assessed by graphical inspection (normal Q-Q plot) and Shapiro-Wilk 
normality test (data not shown). These data characteristics indicate that a 610 
standard Student’s t-test is appropriate to detect changes in the mean % 
micronucleated-NCE between the control group and test group, subject to the 
experimental design implemented. The average standard deviation was 
estimated to be 0.026%. 
 26 
Using the variance estimate, we assessed the power to detect changes of 615 
0.05%, 0.1% and 0.2% micronucleated-NCE for different samples sizes 
when using a two-tailed, two-sampled Student’s t-test47. For hypothesis 
testing of age-, sex- and genetic-background-matched test and control mice, 
we recommend a target power of >0.8. For confirmation of genomic instability 
mutants, we suggest a power ≥ 0.95 (Fig. 3d). The power calculations 620 
demonstrated that the assay is very sensitive and that n = 3 mice per 
genotype is enough to test for differences >0.1% micronucleated-NCE 
(approximately 1.5-fold change for C57BL/6N mice) in a confirmation 
experiment, and that n = 6 mice per genotype are required to test differences 
as low as 0.05% micronucleated-NCE (approximately 1.25-fold change for 625 
C57BL/6N mice) in a screening experiment. The variance of mixed genetic 
backgrounds is greater than for pure genetic backgrounds and this will reduce 
the statistical power (Fig. 3b). 
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Box 2 – DNA damage response challenge: generation of positive control 630 
samples and detection of molecules involved in the response to 
exogenous DNA damaging agents 
DNA damage response (DDR) defects can be revealed by treating mice that 
show normal spontaneous micronucleus frequencies with genotoxic agents. 
Upon treatment, micronuclei form in mitotically dividing erythroid progenitor 635 
cells and can be detected 24-72 hours later in peripheral reticulocytes (Fig. 1 
and Fig. 4a and 4b). This procedure can be used to create positive control 
samples from wild-type control animals or for the identification of deficiencies 
that are only apparent, or amplified, in response to DDR challenge because 
they are only necessary for the response to exogenous DNA damaging 640 
agents rather than endogenous DNA damaging agents. This procedure will 
enable the researcher to detect genes that are not necessary for the response 
to endogenous DDR stress, thus their deregulation does not produce elevated 
spontaneous micronucleus levels, but are critical for the response to DNA 
damage. 645 
 
PROCEDURE TIMING: 3 days. 
1 | Before genotoxic challenge, collect and fix 50 µl of blood as detailed in the 
spontaneous micronucleus procedure (steps 1-3); include an untreated 
control cohort to ensure that the procedure does not cause marked 650 
reticulocytosis (see ‘limitations of the method’ and TROUBLESHOOTING). 
2 | Challenge the animals with the specific genotoxic agent; the 
recommended dose of irradiation is 0.75 Gy whole-body irradiation and the 
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recommended dose of mitomycin C is 1 mg/kg body weight via 
intraperitoneal injection. 655 
3 | Collect and fix 50 µl of blood 24, 48 and 72 hours post-treatment as 
detailed in the spontaneous micronucleus procedure (steps 1-3). 
4 | Continue as detailed in the spontaneous micronucleus procedure (steps 4-
24); 
 660 
ANTICIPATED RESULTS:  Wild-type mice treated with these genotoxins 
show a significant increase in the %micronucleated-RET 24 and 48 hours 
post-treatment and recovery is observed 72 hours post treatment (Fig. 4a and 
4b). For example, 48 hours after 0.75 Gy, wild-type mice have a mean 5-fold 
increase in % micronucleated-RET (baseline mean = 0.61% for n = 10; 48 665 
hours after 0.75 Gy mean = 3.05% for n = 3), whereas 48 hours after 
administration of 1 mg/kg mitomycin C, wild-type mice have a 7-fold increase 
(baseline mean = 0.61% for n = 10; 48 hours after treatment mean = 4.23% 
for n = 3). Genotoxin sensitivity is characterized by a normal % 
micronucleated-RET frequency before treatment but a significant increase in 670 
% micronucleated-RET versus control, 48 hours post-treatment. Fig. 4b 
demonstrates the radiosensitivity of Akt2-/- (tm1a[EUCOMM]WTSI) mice. 
Treatment must be carried out in accordance with the local regulations for the 
use of animals in research. 
 675 
 
Figure legends 
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Figure 1. Micronucleus induction during erythropoiesis. a) Erythropoiesis 
is characterized by maturation of the multipotent hematopoietic stem cell (not 680 
shown) to a smaller, mitotically inactive normoblast. Within the normoblast, 
chromatin begins to condense, and eventually the pyknotic nucleus is 
expelled, yielding a cell that is known as a reticulocyte. The reticuloctyes 
(RET) migrate from the bone marrow to the peripheral circulation, where, one 
or two days later, it matures into a normochromatic erythrocyte (NCE), which 685 
is characterized by degradation of the reticular RNA mesh and loss of 
transferrin receptor (CD71) expression. Micronuclei can form spontaneously 
during the mitotic stages of erythropoiesis, for example, within the multipotent 
hematopoietic stem cell or differentiated precursor cells (normoblasts); 
however, in normal cells this is an extremely rare event. While the nucleus is 690 
expelled during red blood cell maturation, the micronucleus is retained. If cells 
are genomically unstable or mice have been treated with a genotoxin, the 
frequency of micronucleus formation increases. Micronuclei are propidium 
iodide (PI) positive and can be differentially identified in NCE or RET by co-
staining with CD71. b) May-Grumwald Giemsa staining of fresh blood sample 695 
from a wild-type mouse shows a Giemsa positive DNA fragment 
(micronucleus) in an erythrocyte. c + d) DAPI stained micronucleated-
erythrocyte from a blood sample prepared according to the methods indicated 
in this protocol (heparin anticoagulation followed by fixation in -80˚C 
methanol). The methanol-fixed blood was cyto-spun onto a slide and DAPI 700 
stained (panel c| shows staining with overlay phase-contrast/DAPI, whereas 
panel d| shows staining with DAPI alone). Size bars 5 µm. Arrows indicate 
micronuclei. 
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Figure 2. Workflow of micronucleus assay. Mouse blood samples are 705 
collected into liquid heparin solution and fixed in cold methanol. Samples are 
washed in bicarbonate buffer, cells are pelleted and resuspended in buffer, 
before incubation in bicarbonate buffer containing FITC-conjugated anti-
transferrin receptor (CD71) antibody and RNase. Samples are washed out of 
the incubation solution with bicarbonate buffer, and resuspended in buffer 710 
before adding propidium iodide (PI) and collecting 200 000 events by flow 
cytometry.  
 
Figure 32. Effect of sex and genetic background on micronucleus 
induction and determination of statistical power. a) Wild-type female mice 715 
have significantly decreased %micronucleated normochromatic erythrocytes 
(%MN-NCE; mean ± standard deviation: 0.141 ± 0.031; n = 20) relative to 
wild-type males (mean ± standard deviation: 0.209 ± 0.03; n = 20; P = 0.0002, 
mixed model analysis with assay date as a random effect and sex as a fixed 
effect). b) Graph shows %MN-NCE for 16 week old male mice bred on 720 
different genetic backgrounds; the assay is sensitive enough to detect 
significant differences between strains. Data represents mean (bar) and 
standard deviation (error bar):  0.144 ± 0.024, n = 26 129SvEv versus 0.186 ± 
0.025 n = 14 BL6/JIco, P=0.002, mixed model analysis with assay date as a 
random effect and core strain as a fixed effect; 0.208 ± 0.023, n = 46 725 
B6Brd;B6Dnk;B6N-Tyrc-Brd; 0.160 ± 0.051, n=10 B6Brd;129S5-Tyrc-Brd; 0.188 ± 
0.077, n = 10 CBACa;129P2. Note the increased variance for mixed genetic 
backgrounds e.g. 129P2xCBACa, compared to mixed genetic substrains e.g. 
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B6Brd;B6Dnk;B6N-Tyrc-Brd. c) Graph shows data for five technical replicates 
for blood samples obtained from three C57BL/6 wild type male mice. Data 730 
demonstrate that there is good reproducibility when using mice of the same 
sex and genetic background. Data shows mean (bar) and error bars represent 
standard deviation.  d) Power analysis shows the estimated power as the 
number of biological replicates increases. The relationship was studied for 
three effect sizes changes (absolute difference of 0.05, 0.1 or 0.2% MN-NCE). 735 
The dotted lines highlight the target power of 0.8 for a hypothesis generating 
experiment or 0.95 for a hypothesis testing experiment.  
 
Figure 43. Micronucleus induction after genotoxic treatment or genetic 
modification. a) Graph shows mean and standard deviation for induction of 740 
micronucleus (MN) formation in reticulocytes (RET) of wild-type mice treated 
with the DNA crosslinking agent mitomycin C (MMC; 1 mg/kg; n=3) or 0.75 Gy 
ionizing radiation (IR; n = 4), relative to untreated mice (n = 4). Mice were bled 
at the indicated time points, and % MN-RET was calculated as a percentage 
of total RET. Forty eight hours after MMC or IR treatment, %MN-RET is 745 
significantly increased relative to untreated control mice (*P<0.01, Student’s 
two-tailed t-test[AU:  State what error bars are. ] ). b) Graph shows mean and 
standard deviation for n≥5 Akt+/+; Akt+/- and Akt-/- male mice after 0.75 Gy IR. 
Akt-/- mice have a higher frequency of %MN-RET after IR, when compared to 
littermate controls (*P<0.0001; two-tailed Student’s t-test). c-e) Increased 750 
%MN-normochromatic erythrocytes (NCE) in a mouse model of Fanconi 
anaemia. Blood was collected from Slx4+/+ (c) and Slx4-/- (d) mice at 16 weeks 
of age and processed with the high-throughput micronucleus assay protocol. 
Formatted: Font: Italic
Formatted: Font: Italic
 32 
Representative plots are shown. Note the increased frequency of MN-NCE in 
blood obtained from Slx4-/- mice (d) when compared to that of control Slx4+/+ 755 
mice (c). e) Graph shows MN-NCE as a percentage of total NCE. Slx4-/- mice 
have significantly higher levels of spontaneous micronucleus induction than 
Slx4+/+ mice (mean ± standard deviation: 0.21 ± 0.025; Slx4+/+ versus 0.51 ± 
0.078; Slx4-/-; n = 6, B6Brd;B6Dnk;B6N-Tyrc-Brd males for each genotype; 
*P<0.0001, Student’s two-tailed t-test). Data is duplicated from Crossan et al. 760 
201111 to provide an example of a genetic positive control. 
 
Figure 4. Workflow of micronucleus assay. Mouse blood samples are 
collected into liquid heparin solution and fixed in cold methanol. Samples are 
washed in bicarbonate buffer, cells are pelleted and resuspended in buffer, 765 
before incubation in bicarbonate buffer containing FITC-conjugated anti-
transferrin receptor (CD71) antibody and RNase. Samples are washed out of 
the incubation solution with bicarbonate buffer, and resuspended in buffer 
before adding propidium iodide (PI) and collecting 200 000 events by flow 
cytometry.  770 
 
Figure 5. Analysis of micronucleated red blood cells by flow cytometry. 
a) The erythrocyte cell population is resolved from the rest of the cell 
population by region gate R1, created on side scatter logarithmic scale (SSC-
Log) versus forward scatter linear scale (FSC-Lin). b) Single cells are isolated 775 
by region gate R2 on forward scatter width (FSC-W) versus FSC-Lin. c) Auto-
fluorescent cells are excluded by gating on propidium iodide (PI) versus SSC 
(see also Suppl. Fig. 5). d) The gated cells (R1, R2 and R3) are analyzed 
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according to the intensity of fluorescence in the FITC channel (CD71-FITC) 
and the PI channel, and a quadrant gate is drawn to separate the four cell 780 
populations: normochromatic erythrocytes (NCE) are CD71-/PI-; reticulocytes 
(RET) are CD71+/PI-; micronucleated reticulocytes are CD71+/PI+ (MN-RET); 
while micronucleated normochromatic erythrocytes (MN-NCE) are CD71-/PI+.  
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Table 1. Troubleshooting [AU:  Editor has added in step numbers; please check.]  785 
 
Step Problem Possible reason Solution 
2-4 -Samples tinged brown rather than bright red. 
-SSC versus FSC plot; reduction in FSC scattering i.e. population 
shifts left, and the cell populations are less well defined. 
(Suppl. Fig. 2d and f) and 3d-e) 
- Samples have been fixed with 
warm fixative. 
- Samples have become too warm 
during preparation. 
 
- Always use super-chilled methanol (-
80˚C) to fix blood as warmer methanol 
temperatures change the size and 
granularity of blood cells and this results 
in overlap between anuclear red blood 
cells and nuclear white blood cells (SSC 
versus FSC plot). This causes an 
apparent elevation of the micronucleated-
NCE population. Correct fixation is 
indicated by a bright red sample color in 
fixative (Suppl. Fig 2d)and a profile that 
fits the one shown in Fig. 5a.  
-Prepare samples on ice and centrifuge at 
4˚C. 
- If the cellular origin of the PI-positivity is 
in question, we recommend performing 
fresh blood smears and staining with 
May-Grumwald Giemsa  (Fig. 1b) or to 
cyto-spin methanol-fixed samples (e.g. 
from a duplicate 15 ml tube) onto slides 
and co-stain with DAPI (Fig. 1c and 1d). 
13, 22, 23 Debris in bottom left hand corner of SSC versus FSC plot.  
(Suppl. Fig. 3b) 
- Sample degradation. 
- Heparin solution made in water 
and not saline. 
- Always fix the blood sample on the day 
of blood collection. The ideal profile fits 
the one in Fig. 5a. 
17, 22, 23 CD71-FITC+ve-population predominates in Q2 rather than Q1 
(See Suppl. Fig. 2b) 
- PI binds RNA present in 
reticulocytes due to incomplete 
RNase treatment. 
-  
-Try a new batch of RNase and test using 
at least two RNase concentrations. 
-Reduce sample volume and increase 
buffer volume in assay. 
241 Large variability in micronucleated-NCE (Q3) for mice of same 
genotype 
 
-Incubation time in PI was very 
different between samples. (Suppl. 
Fig. 4b) 
-Mice are of a mixed genetic 
background. 
-Genotyping error. 
-Add 1 µl PI to no more than 24 wells at a 
time before data acquisition and do not 
screen samples after 30 minutes 
incubation in PI. As with any good 
experimental practice, sample 
randomization in the plate should be 
used. 
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-Increase sample number. 
-Re-genotype. 
17, 22, 23 Spikes of events in Q2 (FITC versus PI plot) 
(Fig. 3c) 
-Sample is too concentrated and/or 
collection speed is too high 
-Reduce collection speed.  
-If spikes still occur in Q2 during 
acquisition, stop the acquisition and dilute 
the sample in bicarbonate buffer to 
ensure 1000-2000 events per second. 
22, 23 Excessive number of events (>50-fold increase in total 
reticulocytes) in Q1 versus control mouse (RET; see Suppl. Fig. 
1a) 
Reticulocytosis -Extreme reticulocytosis is likely to cause 
a false positive increase in the number of 
FITC-ve, PI+ve events (MN-NCE). 
Therefore it would be preferable to score 
the cells for the presence of a nucleus or 
micronucleus with a microscope after 
smearing methanol fixed blood onto 
slides and co-staining with DAPI (Fig 1c 
and 1d)
13
. 
The flow-cytometric quadrants (FITC versus PI plot ) are defined as Q1: RET; Q2: MN-RET; Q3: MN-NCE; Q4: NCE.   
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Supplementary Figure 1. Severely increased red blood cell production (reticulocytosis) results in detection of nucleated 
and micronucleated (MN) normochromatic erythrocytes (NCE) in Q3. Blood obtained from C57BL/6J-ApcMin/+ mice was 790 
processed according to the methods described herein. a) Representative flow-cytometric analysis for six week old Apc-/min mouse 
(left) and 16 week old Apcmin/+ mice (right). Note the change in % reticulocytes (RET) and %MN-NCE.  During extremely high 
rates of erythropoiesis, such as that exhibited by severely anaemic, aged Apcmin/+ mice (right), the number of reticulocytes 
detected in the RET quadrant is vastly increased, however the process becomes error prone and the nucleus is not always 
expelled; both nucleated and micronucleated red blood cells are detected in the % MN-NCE quadrant, leading to a false-positive 795 
increase in %MN-NCE. b) Data shows %MN-NCE vs. %RET for Apcmin/+ mice (n=4) and Apc+/+ mice (n=10). Linear regression 
analysis shows that there is a significant correlation between increased % MN-NCE and % RET (P<0.01). c) Dot plot showing 
the average %RET in male C57BL/6 mice (mean ± standard deviation: 1.623±0.209; n=20). 
 
Supplementary Figure 2. Effect of RNase, flow rate and fixation.  a) Blood sample obtained from male C57BL/6 mouse at 16 800 
weeks of age, processed according to the methods described herein. b) The same sample was processed without the addition of 
RNase, which results in a shift of the FITC-conjugated transferrin receptor-positive (CD71-FITC+), propidium iodide negative (PI-
) reticulocyte (RET) population over to the micronucleated-RET (MN-RET) quadrant. This is caused by PI binding to the RNA 
within the CD71-FITC+ RETs. c) Sample analyzed at a rate of 10000 events per second (vs. 1000 events in a) shows spikes of 
events in the CD71-FITC+ and PI+ quadrant (indicated by arrow head). d) The color of fixed samples can indicate whether 805 
samples have become too warm during preparation. Fresh blood samples were harvested and fixed in -80°C methanol in 
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duplicate or in room temperature (RT; 20-25°C) methanol. The blood fixed in -80°C methanol shows characteristic red color while 
the sample fixed in RT methanol shows brown color. e) Samples maintained for long periods of time in -80°C methanol show 
characteristic red color and are suitable for processing. f) The same samples (from image d) were either placed in a -80°C 
freezer or left at RT. After 30 minutes the sample that was maintained at -80°C showed the characteristic red color while the 810 
sample that was left at RT became brown in color; no detectable change in color was seen at the sample fixed in RT methanol. 
 
Supplementary Figure 3. Indicators of incorrect sample processing. a) Correctly prepared sample. Blood sample obtained 
from male C57BL/6 mouse at 16 weeks of age, processed according to the methods described herein. The SSC-A vs. FSC-A 
plot (left) reveals correct separation of blood cell populations and minimal cell debris and the CD71-FITC vs. PI plot (right) 815 
reveals correct representation of populations within the quadrant gates. b) Slightly degraded blood sample. Blood sample left 5 
days at 4˚C and fixed in -80˚C methanol. The SSC-A vs. FSC-A plot (left) reveals increased cell debris (black arrow) and 
incomplete separation of the cell populations. The gated populations plotted on CD71-FITC vs. PI plot (right) show no indication 
of degradation but there is a slight increase in MN-NCE (right). c) Very degraded blood sample. Blood sample left 3 weeks at 4˚C 
and fixed in -80˚C methanol. Both the SSC-A vs. FSC-A and CD71-FITC vs. PI plots are completely transformed. d) Blood 820 
sample fixed in warm methanol (room-temperature). The SSC-A vs. FSC-A plot (left) reveals increased cell debris (black arrow) 
and the CD71-FITC vs. PI plot (right) shows incorrect representation of populations. e) Blood sample fixed correctly (-80˚C 
methanol) but allowed to warm to room temperature (20-25°C) before processing. The SSC-A vs. FSC-A plot (left) reveals 
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increased cell debris (black arrow) and incomplete separation of the cell populations, and the CD71-FITC vs. PI plot (right) 
shows incorrect representation of populations.  825 
 
Supplementary Figure 4. Effect of incubation time in propidium iodide (PI) and time in storage. a) Data shows %MN-NCE 
for replicate tubes of the same sample that were stored at -80˚C. Two tubes were processed at monthly intervals over a one-year 
period. Linear regression analysis shows that there is no significant difference in the detection of % MN-NCE up to one year after 
fixation (P=0.427). b) A single blood sample was added to each well of a 96-well plate and processed accordingly. After washing 830 
with buffer to remove the FITC-conjugated transferrin receptor (CD71-FITC)/RNase mix, samples were resuspended in buffer 
containing 1 mg/ml PI, and all 96 wells were immediately analyzed by flow-cytometry. Linear regression analysis shows that 
there is a statistically significant difference in the % micronucleated (MN)-normochromatic erythrocytes (NCE) obtained at the 
beginning of the plate versus those obtained at the end of the plate (*P<0.001). This could be due to saturation of DNA with PI 
over time. The biological effect is small but to avoid potential experimental bias, samples should be randomized across the plate 835 
and we recommend adding PI to 24 wells at a time. 
 
Supplementary Figure 5. Flow cytometric analysis of control samples and gating out autofluoresence.  Unstained 
samples are used to centralise the main cell population within the side scatter (SSC) versus forward scatter (FSC) plot (data not 
shown). The main population is gated (erythrocytes), and within the propidium iodide (PI) versus FITC-conjugated transferrin 840 
receptor (CD71-FITC) plot a quadrant gate is drawn. Single-stain controls are then analysed to determine the correct voltage and 
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gain settings, which ensures the majority of events fall within the scale of the X and Y axes, and within the correct quadrant gate. 
a) Unstained control sample and b) CD71-FITC alone. Auto-fluorescence can be detected with samples stained with PI alone, 
either within the transferrin receptor FITC-conjugated (CD71-FITC) channel (c; indicated by arrowhead), or within the higher 
logarithmic scale (Log) of PI channel (d; indicated by arrowhead). To remove the effect of auto-fluorescence, Region gate R3 is 845 
created within the PI versus side scatter (SSC) plot (d). 
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